Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study points to potential new use for Viagra

28.08.2008
A “basic science” breakthrough by Queen’s researchers into regulating a single enzyme may lead to new drug therapies that will help prevent heart attacks and strokes.

Led by professor of Pharmacology and Toxicology Donald Maurice, the study focuses on the effects of Viagra – the popular erectile dysfunction drug, which is also used to treat pulmonary hypertension.

The team’s findings will be published on-line this week in the international journal Proceedings of the National Academy of Sciences (PNAS).

“As scientists, we’re excited about this discovery because it’s a fundamentally new approach to regulating what enzymes do in cells,” says Dr. Maurice, a Career Scientist with the Ontario Heart and Stroke Foundation. “The fact that it also offers a potentially novel use of a drug already widely in use for other applications is an unexpected bonus.”

The enzyme targeted by the Queen’s researchers is known to regulate the activity of platelets: small blood cells needed for normal blood clotting. Problems can arise when people have stents permanently implanted in their arteries to maintain blood flow. Their platelets sometimes bind to the stent and, if enough platelets accumulate to form a blockage, this may cause a sudden, massive heart attack or stroke to occur.

Drugs like Viagra have been shown to inhibit PDE5, explains Lindsay Wilson, a PhD student in Pathology and Molecular Medicine and first author on the study. Until now, however, it hasn’t been possible to isolate the small “pool” of activity within the cell where this is occurring.

The Queen’s study shows that within each cell there are two different pools of the PDE5 enzyme, but that only one of them regulates platelet activation. “Understanding how the cell works should allow us to affect the activity of enzymes in one neighborhood – and leave alone their ‘identical twins’ in a different neighborhood in that cell,” says Ms Wilson.

“The idea is to use a PDE5 inhibitor such as Viagra selectively to inhibit platelet function,” she continues. We now know that not all the enzymes in the cell are doing the same job. Just like in real estate, it’s all about the location!”

Other members of the Queen’s research team are Hisham Elbatarny and Brian Bennett (Pharmacology and Toxicology), and Scott Crawley (Biochemistry). Funding came from the Ontario Heart and Stroke Foundation and the Canadian Institutes of Health Research (CIHR).

PLEASE NOTE: A PDF copy of the study is available upon request.

Nancy Dorrance, nancy.dorrance@queensu.ca, 613.533.2869 or Molly Kehoe, molly.kehoe@queensu.ca, 613.533.2877, Queen's News & Media Services.

Nancy Dorrance | EurekAlert!
Further information:
http://www.queensu.ca

More articles from Studies and Analyses:

nachricht The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung

nachricht A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>